Mealey's PI/Product Liability - Mallinckrodt Pays $15.4M For Questcor Actions While Opposing False Claims Suit

STAINES-UPON-THAMES, England - British drug maker Mallinckrodt PLC on Sept. 3 said it has finalized a $15.4 million agreement to settle a false claims investigation by the U.S. Justice Department into "legacy sales and marketing activities" by Questcor Pharmaceuticals Inc. before Questcor was bought by Mallinckrodt.
Find full version on lexis Advance®